Prediction of survival by degree of reactivity to BCG in patients with metastatic breast cancer.
D001500:BCG Vaccine / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000473:pathology / Q000628:therapy*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D009362:Neoplasm Metastasis; D011379:Prognosis
D001500:BCG Vaccine